Evropska unija - slovenščina - EMA (European Medicines Agency)

laboratoires delbert - histamin dihydrochloride - leukemija, myeloid, akutna - immunostimulants, - ceplene maintenance therapy is indicated for adult patients with acute myeloid leukaemia in first remission concomitantly treated with interleukin-2 (il-2). učinkovitost zdravila ceplene ni bila v celoti dokazana pri bolnikih, starejših od 60 let.

Evropska unija - slovenščina - EMA (European Medicines Agency)

esteve pharmaceuticals gmbh - zikonotid - injections, spinal; pain - analgetiki - zikonotid je indiciran za zdravljenje hude, kronične bolečine pri bolnikih, ki potrebujejo intratekalno (it) analgezijo.

Evropska unija - slovenščina - EMA (European Medicines Agency)

merck sharp & dohme b.v. - insulin glargin - sladkorna bolezen - zdravila, ki se uporabljajo pri diabetesu - zdravljenje diabetesa mellitusa pri odraslih, mladostnikih in otrocih, starih 2 leti in več.

Evropska unija - slovenščina - EMA (European Medicines Agency)

cheplapharm arzneimittel gmbh - pioglitazone, glimepiride - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - tandemact je indicirano za zdravljenje bolnikov s sladkorno boleznijo tipa 2, ki kažejo nestrpnosti v metforminom ali za katere je kontraindiciran metformin in ki se že zdravijo s kombinacijo pioglitazone in glimepiride.

Evropska unija - slovenščina - EMA (European Medicines Agency)

pfizer europe ma eeig - krizotinib - karcinom, pljučni pljuč - antineoplastična sredstva - xalkori as monotherapy is indicated for:the first‑line treatment of adults with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc)the treatment of adults with previously treated anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc)the treatment of adults with ros1‑positive advanced non‑small cell lung cancer (nsclc)the treatment of paediatric patients (age ≥6 to.

Evropska unija - slovenščina - EMA (European Medicines Agency)

pierre fabre medicament - propranolol hidroklorid - hemangioma - beta blokatorji - hemangiol is indicated in the treatment of proliferating infantile haemangioma requiring systemic therapy: , life- or function-threatening haemangioma,, ulcerated haemangioma with pain and/or lack of response to simple wound care measures,, haemangioma with a risk of permanent scars or disfigurement. , it is to be initiated in infants aged 5 weeks to 5 months.

Evropska unija - slovenščina - EMA (European Medicines Agency)

vifor fresenius medical care renal pharma france - difelikefalin - pruritus - vsi drugi terapevtski izdelki - kapruvia is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis (see section 5.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

merck d.o.o. - bisoprolol - filmsko obložena tableta - bisoprolol 8,49 mg / 1 tableta - bisoprolol

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

merck d.o.o. - bisoprolol - filmsko obložena tableta - bisoprolol 4,24 mg / 1 tableta - bisoprolol

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

pfizer luxembourg sarl - bisoprolol - filmsko obložena tableta - bisoprolol 4,24 mg / 1 tableta - bisoprolol